Concept information
Preferred term
Methyldopa
Type
-
mesh:Descriptor
Definition
- An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
Broader concept
Narrower concepts
Entry terms
- 2579Z4P04J
- 555-30-6 (Methyldopa)
- 56LH93261Y
- alpha-Methyldopa
- Alphamethyldopa
- alpha-Methyl-L-Dopa
- L-Tyrosine, 3-hydroxy-alpha-methyl-
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
2579Z4P04J
-
555-30-6 (Methyldopa)
-
56LH93261Y
-
alpha-L-Méthyldopa
-
alpha-Méthyldopa
-
L-Tyrosine, 3-hydroxy-alpha-methyl-
URI
http://data.loterre.fr/ark:/67375/JVR-XWGWH230-B
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}